Psychiatry & Neurology, Clinical Neurophysiology · Las Vegas, NV
NPI
1669693081
Since 2007
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2110 E Flamingo Rd Ste 201
Las Vegas, NV, 89119
Phone (702) 800-7831
Groups this clinician bills Medicare through
Medicare paid, 2024
$97K
4,148 services
Medicare patients, 2024
175
Average age 72
Drug cost, 2024
$3.1M
1,119 prescriptions
Company payments, 2025
$2,869
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edgar J Evangelista was code 99213 (office e&m - established), 306 times for 143 patients. In total Edgar J Evangelista billed 4,148 services in 34 codes, and Medicare paid $97K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 306 | 143 | $66.89 | $20K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 109 | 81 | $12.48 | $1,360 |
| 95886 Electrical Nerve Conductivity | Office | 106 | 41 | $74.50 | $7,896 |
| 99204 Office E&M - New | Office | 63 | 63 | $124.99 | $7,875 |
| 95887 Electrical Nerve Conductivity | Office | 53 | 41 | $64.40 | $3,413 |
| 99214 Office E&M - Established | Office | 34 | 31 | $92.58 | $3,148 |
| 95923 Electrical Nerve Conductivity | Office | 25 | 25 | $95.06 | $2,377 |
| 95909 Electrical Nerve Conductivity | Office | 23 | 22 | $104.25 | $2,398 |
| 95819 Neurologic | Office | 22 | 22 | $354.20 | $7,792 |
| 92540 Vision, Hearing, and Speech Services | Office | 14 | 14 | $77.57 | $1,086 |
| 92537 Test - Miscellaneous | Office | 14 | 14 | $30.91 | $433 |
| 92546 Vision, Hearing, and Speech Services | Office | 14 | 14 | $103.50 | $1,449 |
| 92548 Test - Miscellaneous | Office | 14 | 14 | $36.59 | $512 |
| 92547 Vision, Hearing, and Speech Services | Office | 14 | 14 | $8.33 | $117 |
| 95913 Electrical Nerve Conductivity | Office | 13 | 13 | $221.38 | $2,878 |
By year: 2022 $83K for 4,316 services; 2023 $58K for 2,551 services; 2024 $97K for 4,148 services.
Medicare prescription drug claims, 2024
In 2024, the drug Edgar J Evangelista prescribed most often to Medicare patients was Gabapentin, with 71 prescriptions and refills. In total Edgar J Evangelista wrote 1,119 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 71 | 94 | 18 | $1,081 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 48 | 48 | Under 11 | $1.5M |
| Levetiracetam Generic | 45 | 104 | 11 | $2,451 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 44 | 90 | Under 11 | $1,287 |
| Sumatriptan Succinate Generic | 44 | 44 | 11 | $260 |
| Donepezil Hcl Generic | 40 | 52 | 12 | $458 |
| Sodium Chloride 0.9 % Sodium Chloride | 39 | 39 | Under 11 | $272 |
| Meloxicam Generic | 34 | 34 | Under 11 | $92.45 |
| Primidone Generic | 33 | 45 | Under 11 | $1,187 |
| Lacosamide Generic | 33 | 45 | Under 11 | $1,075 |
| Memantine Hcl Generic | 29 | 51 | Under 11 | $639 |
| Topiramate Generic | 28 | 40 | Under 11 | $226 |
| Lamotrigine Generic | 27 | 45 | Under 11 | $229 |
| Emgality Pen Galcanezumab-Gnlm | 27 | 31 | Under 11 | $21K |
| Cyclobenzaprine Hcl Generic | 25 | 25 | Under 11 | $163 |
Brand drugs: - claims; generic drugs: 855 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edgar J Evangelista $2,869 ($2,869 in general payments such as food, travel and fees) from 23 companies. The largest payer was Abbvie Inc. with $419.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 26 | $419 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $258 |
| Eisai Inc. 4523.T | 20 | $253 |
| Pfizer Inc. PFE | 13 | $252 |
| Argenx US, Inc. ARGX | 10 | $213 |
| EMD Serono, Inc. MRK.DE | 7 | $177 |
| Celgene Corporation BMY | 13 | $160 |
| Axsome Therapeutics, Inc. AXSM | 6 | $134 |
| Biogen, Inc. BIIB | 5 | $124 |
| Teva Pharmaceuticals USA, Inc. TEVA | 4 | $121 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.